I was thinking along the same lines SF.....about the focus on having Apabetalone accepted by those who would be perscribing it to patients.  This focus I think might serve as an indication that the company's confidence is high about eventual approval.  

Of note was this part:  New Expanded Global SERMO Market Outreach Program Underway

I don't recall seeing anything about SERMO before, I myself had never even heard of it:  http://www.sermo.com/